Skip to main content
Clinical Trials/NCT05599321
NCT05599321
Recruiting
N/A

Piloting a Virtual Navigation (VN) System for Bronchoscopic Lung Nodule Sampling

Penn State University1 site in 1 country166 target enrollmentJune 16, 2023
ConditionsLung Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Penn State University
Enrollment
166
Locations
1
Primary Endpoint
Functionality measurement
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The overall goal is to evaluate the role of a Virtual Navigation (VN) system (the Virtual Navigator) in the bronchoscopic evaluation and tissue sampling of lung cancer and other chest lesions at the Penn State Hershey Medical Center (HMC). The Virtual Navigator is a software package that runs on a mobile Windows-based computer. The computer takes in up to four clinical image/video sources, ordered by the clinician for clinical purposes: 1) 3D CT (computed tomography) imaging scan; 2) 3D PET (positron emission tomography) imaging scan (optional); 3) Bronchoscopic video of the airway tree interior; 4) Ultrasound video of scanned anatomy outside the airways, as provided by an endobronchial ultrasound (EBUS) probe (optional). During a live guided procedure, the Virtual Navigator presents images that assist with navigating the bronchoscope to predesignated chest lesions.

Lung cancer patients that present a suspicious peripheral tumor on their chest CT scan are often prescribed to undergo a diagnosis-and-staging bronchoscopy, whereby the bronchoscopist examines both the suspect tumor and any identified central-chest lymph nodes. For the clinical study, we consider bronchoscopy performance for two cohorts: 1) a cohort of consented patients who undergo image-guided bronchoscopy via the Virtual Navigator; and 2) a historical controls cohort consisting of patients who underwent bronchoscopy recently at our medical center (state-of-the-art bronchoscopy practice). The study's general hypothesis is that an image-guided bronchoscopy system (the Virtual Navigator) that integrates 3D imaging, bronchoscopy, and EBUS images enables more complete evaluation and sampling of chest lesions than current state-of-the-art clinical techniques. More specifically, for peripheral-tumor diagnosis, the sub-hypothesis is that the VN system increases diagnostic biopsy yield as compared to state-of-the-art bronchoscopy practice; for central-chest nodal staging, the sub-hypothesis is that the VN system enables the sampling of more lymph nodes than state-of-the-art bronchoscopy practice.

Registry
clinicaltrials.gov
Start Date
June 16, 2023
End Date
October 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

William E. Higgins

Distinguished Professor

Penn State University

Eligibility Criteria

Inclusion Criteria

  • patients from age 18 and over
  • a planned clinical bronchoscopy to evaluate abnormal lung parenchyma and/or central chest lymph nodes
  • a clinical CT scan performed at Hershey Medical Center that meets technical specifications and is available on the Radiology research server
  • (Optional, use if available) CT/PET images that meet technical specifications and are available on the Hershey Medical Center clinical image storage system

Exclusion Criteria

  • inability to give consent
  • the CT scan does not meet technical specifications

Outcomes

Primary Outcomes

Functionality measurement

Time Frame: 1 years

Presence or absence of software malfunctions in the VN System during bronchoscopic procedure

Diagnostic biopsy yield

Time Frame: 2 years

Comparison of diagnostic biopsy yield between the live cases and historical controls

Number of lymph nodes visited

Time Frame: 2 years

Comparison of number of lymph nodes visited between the live cases and historical controls

Safety measurement

Time Frame: 1 years

Presence or absence of errors in the VN System during bronchoscopic procedure

Secondary Outcomes

  • Biopsy samples(2 years)
  • Tumor pathology(2 years)
  • Procedure complications(2 years)
  • Distance from biopsy site to optimal site(2 years)
  • Procedure time(2 years)

Study Sites (1)

Loading locations...

Similar Trials